31Jul, 2026

BioTrack Sibionics CGM

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Uncategorized

26Mar, 2026

Zeptide 15mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 2161

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

26Mar, 2026

Zeptide 12.5mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 1836

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

26Mar, 2026

Zeptide 10mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 2401

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

26Mar, 2026

Zeptide 7.5mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 4039

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

26Mar, 2026

Zeptide 5mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 1693

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

26Mar, 2026

Zeptide 2.5mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 1037

Therapeutic area:

Weight Management/Obesity

Description:

Description: Zeptide (Tirzepatide) contains a once-weekly GIP receptor and GLP-1 receptor agonist. It is indicated for type 2 diabetes mellitus and chronic weight management.

16Sep, 2024

Sematide 1.0mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 3404

Therapeutic area:

Diabetes

Description:

Description: Sematide is Glucagon-like peptide 1 (GLP1), which is used to control blood sugar by patients with type 2 diabetes and obesity

16Sep, 2024

Sematide 0.50mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 22111

Therapeutic area:

Diabetes

Description:

Description: Sematide is Glucagon-like peptide 1 (GLP1), which is used to control blood sugar by patients with type 2 diabetes and obesity

15Sep, 2024

Sematide 0.25mg

administrator

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic 1258

Therapeutic area:

Diabetes

Description:

Description: Sematide is Glucagon-like peptide 1 (GLP1), which is used to control blood sugar by patients with type 2 diabetes and obesity